AbbVie ABBV
NYSE ABBV
$266.50 +2.16 (+0.82%)
As of: Sep 28, 2026 · 3:59 PM EDT

AbbVie (ABBV) Long-Term Debt Issuances (2015 - 2026)

Updated

AbbVie's Long-Term Debt Issuances came in at $7.99 billion for Q1 2026, up 100.1% from $3.99 billion a year earlier.

Analysis

AbbVie (ABBV) Long-Term Debt Issuances (2015 - 2026) Analysis & Trends

For FY2025, AbbVie's Long-Term Debt Issuances was $3.99 billion, down 76.5% from FY2024.

  • Long-Term Debt Issuances carries a five-year compound annual growth rate of 5.9% (FY2020 to FY2025).
  • Going back by year, Long-Term Debt Issuances was $16.96 billion in FY2024, $2 billion in FY2022 (+100.0%) and $1 billion in FY2021 (-66.7%).
  • The Q1 2026 figure represents the highest quarterly Long-Term Debt Issuances since Q1 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Johnson & Johnson 653.54 Bn 572.07 Bn 17.26 Bn -
2 AbbVie 467.01 Bn 440.17 Bn 12.70 Bn -
3 Merck 367.16 Bn 321.59 Bn 12.21 Bn -
4 Novartis Ag 277.56 Bn 233.43 Bn 11.24 Bn 1.98 Bn
5 Astrazeneca 258.23 Bn 231.79 Bn 12.86 Bn -
6 Amgen 224.14 Bn 179.54 Bn 7.24 Bn -
7 Gilead Sciences 187.30 Bn 161.42 Bn 6.22 Bn -
8 Pfizer 163.47 Bn 110.41 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 133.31 Bn 105.31 Bn 2.84 Bn -
10 Bristol Myers Squibb 128.45 Bn 79.72 Bn 9.25 Bn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 7.99 Bn
Mar 31, 2025 3.99 Bn
Dec 31, 2024 2.00 Bn
Mar 31, 2024 14.96 Bn
Mar 31, 2022 2.00 Bn
Sep 30, 2021 1.00 Bn
Dec 31, 2019 29.95 Bn
Dec 31, 2016 3.86 Bn
Dec 31, 2015 4.00 Bn
Sep 30, 2015 5.00 Mn
API Access

AbbVie Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=ABBV&period=max&api_key=YOUR_API_KEY